Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Web chat site data,
View:
Post by canadafan on Jan 22, 2024 3:40pm

Web chat site data,

Those who know me ( I have been on SH since pre Y2k).
Yes, I will only post what I believe to be true & try to be as informative as possible.
no, I will not bash, mangement or the company & generally refrain from mentioning others.
pumper?
No I have integrity. Meaning if I felt bad about this company, mangement etc. I'd sell & move on.
There are 1000s os stocks to " invest" in " trade" etc.
i do have a lot of Onc shares, & have been buying as of last few weeks, not selling.
My opinion, the SP is extremely undervalued compared to upside potential.
yes I agree 100% things MUST happen to see the SP be realized.
again, my opinion , a buyout is best case opportunity.
in closing, before he adds his useless bashing, childish banter.
a heads up.
buckhenry Has posted well over 300 entries. Not one of which contained anything positive.
Onky open statements, either bashing other contributors, the mangement or the company.
now in a quick analysis, either he is a psychopath or a shorter, paid basher.
afterall , who would put such an effort in discrediting their own investemt
Comparably on another site a poster keeps, without pause calling Onc a fraud?
perhaps he needs to inform PanCan, Roche, Incyte, the FDA & countless others of this fraud & his surperior Intelligence
ONC has missed deadlines, The most recent & devistating the PanCan pullback of the enhanced phase 3 trial.
That is 100% to do with PanCan funding model from the USA federal Gov changes.
yet, they still committed to the $5 million pledge for onc to  move forward with another segrmnt o& the pancreatic cancer world.
regardless long road behind. The road ahead will & must be resolved very soon.
lets hope for the best.
Comment by lonc17 on Jan 22, 2024 5:10pm
I think there is equal chance that CanadaFan is one of the following: 1. A early investor and true believer in ONC. Likely has 20,000 plus shares and has lost more than 95% of his original investment, but wakes up every day hoping for a miracle.   2. A childhood friend of Matt Coffey... has created the persona "CanadaFan" to forever pump ONC as a favor to MC. Likely gets paid ...more  
Comment by Buckhenry on Jan 22, 2024 6:08pm
I think all the pumpers are just one entity with many accounts. It is quite sad to hear that canuckfan has been in this stock that's long. Just think if you had bought something worthwhile back then like Amazon or Apple!!!!!  Instead of this dog.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities